$IRLA
IRulya Therapeutics Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New Haven, CT
IRLA chart
What traders are saying about $IRLA
Latest postsIRulya Therapeutics Inc. news
- Top 5 More Healthcare Gainers Among the Market Movers on November 10, 2026: Senseonics (NASDAQ:SENS) +26.12%, Zura Bio (NASDAQ:ZURA) +19.31%, Harrow, Inc. (NASDAQ:HROW) +15.85%, Zentalis (NASDAQ:ZNTL) +12.36%, IRulya Therapeutic
kalkine.ca ·
- IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Form 144 IRulya Therapeutics For: 6 November By Investing.com
Investing.com Canada ·
- A trust reported a $104K trade in IRulya Therapeutics (IRLA).
Stock Titan ·
- IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst Conference
Yahoo Finance ·
IRulya Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$84.0M | -$56.8M | -$31.4M | -$51.7M |
| Diluted EPS | $-1.68 | $-1.31 | $-0.84 | $-1.54 |
| Total assets (year end) | $93.5M | $114.5M | $167.9M | $103.9M |
| Cash and equivalents (year end) | $5.8M | $6.2M | – | $40.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About IRulya Therapeutics Inc.
- Ticker
- IRLA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- New Haven, CT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1662774
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
Frequently asked questions
What exchange is IRulya Therapeutics Inc. listed on?
IRulya Therapeutics Inc. trades on the Nasdaq under the ticker symbol IRLA.
What industry is IRulya Therapeutics Inc. in?
IRulya Therapeutics Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is IRulya Therapeutics Inc. headquartered?
IRulya Therapeutics Inc.'s business address on file with the SEC is in New Haven, CT.
When does IRulya Therapeutics Inc.'s fiscal year end?
IRulya Therapeutics Inc.'s fiscal year ends on December 31.